Head & Neck Cancer

Patients with head and neck cancer experienced a decrease in symptom severity after using mobile and sensor technology that allowed their health care providers to remotely monitor symptoms, according to research that will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

When compared to chemotherapy, the immunotherapy agent had better outcomes both in quality of life and survival.

Higher carbohydrate and sugar intake was correlated with worse outcomes in patients with head and neck cancer, according to the study.

The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.

After being diagnosed with a rare cancer, professional runner Gabriele Grunewald became inspired to start a nonprofit that raised awareness for other rare cancers and empowered those who have them.

I found my husband there in the dream. He was alive. He was healthy. He could talk again.

After a recent FDA approval for an additional dosing schedule option for Opdivo, patients must be educated on the potential side effects that may occur between prolonged visits.

NFL Hall of Famer Jim Kelly confirmed his cancer has returned, according to recently issued statements from the Buffalo Bills.

These findings bring light to a pressing problem in this patient population, and will hopefully pave the way for more awareness and potential change in practices.

A variety of factors go in to the staging of a head and neck cancer diagnosis, however, the number of malignant lymph nodes may very well be the key to prognosis and treatment moving forward in this patient population.

Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.

There are people out there who have never dealt with a devastating loss, yet apparently are experts when it comes to losing a spouse.

Joshua Bauml, M.D., assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the potential of therapeutic vaccine in patients who have head and neck cancer.

Physical therapy can boost quality of life for patients with cancer, but it isn’t always prescribed.

Tailored survivorship care plans (SCPs) may be beneficial for survivors of head and neck cancer, according to recent research.

A recent study showed that patients with head and neck cancer who had greater depressive symptoms had shorter survival, higher rates of chemoradiation interruption and poorer treatment response. However, there are ways to manage these symptoms.

Oral mucositis causes pain, the inability to eat which can also lead to nutritional problems, and an increased risk for infection as a result of open sores. In turn, these symptoms can lead to reduced quality of life, chemotherapy or radiation dose-limiting, and increased treatment costs from antibiotics or narcotics or additional or longer hospital stays.

Looking back in 2018, I am so glad that we sought out the other opinions. Nerve wracking as it was, the process opened up other options we would not have known about.

“As the population of cancer survivors continues to grow, so does the importance of addressing the long-term sequelae of cancer treatment,” the authors wrote. “This hearing loss can result in multifaceted decrease in quality of life, and in pediatric patients it can impact social and academic development.”

Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.

Michael D. Becker, cancer survivor and author of “A Walk With Purpose: Memoir of a Bioentrepreneur” discusses how he realized that he had head and neck cancer.

Patients with head and neck squamous cell carcinoma (HNSCC) saw an improvement or stabilization in quality of life when they were treated with Opdivo.

Patients with squamous cell carcinoma of the head and neck (SCCHC) and those with melanoma saw some promising activity with the drug combination of epacadostat and Opdivo (nivolumab), according to findings from the phase 1/2 ECHO-204 study presented at the 2017 ASCO Annual Meeting.

Smoking is a risk factor for a number of different types of head and neck cancers, but quitting is not always easy.

Minimally invasive approaches are being explored to lower associated adverse events and, overall, improve patient outcomes for patients with head and neck cancer.